List of Tables
Table 1. Global Anti-IFNAR1 Monoclonal Antibody Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Anti-IFNAR1 Monoclonal Antibody Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Anti-IFNAR1 Monoclonal Antibody Market Competitive Situation by Manufacturers in 2025
Table 4. Global Anti-IFNAR1 Monoclonal Antibody Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Anti-IFNAR1 Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Anti-IFNAR1 Monoclonal Antibody Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Anti-IFNAR1 Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Anti-IFNAR1 Monoclonal Antibody, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Anti-IFNAR1 Monoclonal Antibody, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Anti-IFNAR1 Monoclonal Antibody, Product Types and Applications
Table 12. Global Key Manufacturers of Anti-IFNAR1 Monoclonal Antibody, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-IFNAR1 Monoclonal Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anti-IFNAR1 Monoclonal Antibody Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-IFNAR1 Monoclonal Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Anti-IFNAR1 Monoclonal Antibody Sales by Region (K Units), 2021–2026
Table 18. Global Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Region (2021–2026)
Table 19. Global Anti-IFNAR1 Monoclonal Antibody Sales by Region (K Units), 2027–2032
Table 20. Global Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Region (2027–2032)
Table 21. Global Anti-IFNAR1 Monoclonal Antibody Revenue by Region (US$ Million), 2021–2026
Table 22. Global Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Region (2021–2026)
Table 23. Global Anti-IFNAR1 Monoclonal Antibody Revenue by Region (US$ Million), 2027–2032
Table 24. Global Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Region (2027–2032)
Table 25. North America Anti-IFNAR1 Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Anti-IFNAR1 Monoclonal Antibody Sales by Country (K Units), 2021–2026
Table 27. North America Anti-IFNAR1 Monoclonal Antibody Sales by Country (K Units), 2027–2032
Table 28. North America Anti-IFNAR1 Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 29. North America Anti-IFNAR1 Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Anti-IFNAR1 Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Anti-IFNAR1 Monoclonal Antibody Sales by Country (K Units), 2021–2026
Table 32. Europe Anti-IFNAR1 Monoclonal Antibody Sales by Country (K Units), 2027–2032
Table 33. Europe Anti-IFNAR1 Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Anti-IFNAR1 Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Anti-IFNAR1 Monoclonal Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Anti-IFNAR1 Monoclonal Antibody Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Anti-IFNAR1 Monoclonal Antibody Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Anti-IFNAR1 Monoclonal Antibody Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Anti-IFNAR1 Monoclonal Antibody Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Anti-IFNAR1 Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Anti-IFNAR1 Monoclonal Antibody Sales by Country (K Units), 2021–2026
Table 42. Latin America Anti-IFNAR1 Monoclonal Antibody Sales by Country (K Units), 2027–2032
Table 43. Latin America Anti-IFNAR1 Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Anti-IFNAR1 Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Anti-IFNAR1 Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Anti-IFNAR1 Monoclonal Antibody Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Anti-IFNAR1 Monoclonal Antibody Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Anti-IFNAR1 Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Anti-IFNAR1 Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 50. Global Anti-IFNAR1 Monoclonal Antibody Sales (K Units) by Type (2021–2026)
Table 51. Global Anti-IFNAR1 Monoclonal Antibody Sales (K Units) by Type (2027–2032)
Table 52. Global Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Type (2021–2026)
Table 53. Global Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Type (2027–2032)
Table 54. Global Anti-IFNAR1 Monoclonal Antibody Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Anti-IFNAR1 Monoclonal Antibody Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Type (2021–2026)
Table 57. Global Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Type (2027–2032)
Table 58. Global Anti-IFNAR1 Monoclonal Antibody Price (US$/Unit) by Type (2021–2026)
Table 59. Global Anti-IFNAR1 Monoclonal Antibody Price (US$/Unit) by Type (2027–2032)
Table 60. Global Anti-IFNAR1 Monoclonal Antibody Sales (K Units) by Application (2021–2026)
Table 61. Global Anti-IFNAR1 Monoclonal Antibody Sales (K Units) by Application (2027–2032)
Table 62. Global Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Application (2021–2026)
Table 63. Global Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Application (2027–2032)
Table 64. Global Anti-IFNAR1 Monoclonal Antibody Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Anti-IFNAR1 Monoclonal Antibody Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Application (2021–2026)
Table 67. Global Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Application (2027–2032)
Table 68. Global Anti-IFNAR1 Monoclonal Antibody Price (US$/Unit) by Application (2021–2026)
Table 69. Global Anti-IFNAR1 Monoclonal Antibody Price (US$/Unit) by Application (2027–2032)
Table 70. Chongqing Genrix Biopharmaceutical Company Information
Table 71. Chongqing Genrix Biopharmaceutical Description and Business Overview
Table 72. Chongqing Genrix Biopharmaceutical Anti-IFNAR1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Chongqing Genrix Biopharmaceutical Anti-IFNAR1 Monoclonal Antibody Product
Table 74. Chongqing Genrix Biopharmaceutical Recent Developments/Updates
Table 75. Biotyscience Company Information
Table 76. Biotyscience Description and Business Overview
Table 77. Biotyscience Anti-IFNAR1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Biotyscience Anti-IFNAR1 Monoclonal Antibody Product
Table 79. Biotyscience Recent Developments/Updates
Table 80. Assaygenie Company Information
Table 81. Assaygenie Description and Business Overview
Table 82. Assaygenie Anti-IFNAR1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Assaygenie Anti-IFNAR1 Monoclonal Antibody Product
Table 84. Assaygenie Recent Developments/Updates
Table 85. Selleck Company Information
Table 86. Selleck Description and Business Overview
Table 87. Selleck Anti-IFNAR1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Selleck Anti-IFNAR1 Monoclonal Antibody Product
Table 89. Selleck Recent Developments/Updates
Table 90. EIAab Company Information
Table 91. EIAab Description and Business Overview
Table 92. EIAab Anti-IFNAR1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. EIAab Anti-IFNAR1 Monoclonal Antibody Product
Table 94. EIAab Recent Developments/Updates
Table 95. Thermo Fisher Scientific Company Information
Table 96. Thermo Fisher Scientific Description and Business Overview
Table 97. Thermo Fisher Scientific Anti-IFNAR1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Thermo Fisher Scientific Anti-IFNAR1 Monoclonal Antibody Product
Table 99. Thermo Fisher Scientific Recent Developments/Updates
Table 100. Sino Biological Company Information
Table 101. Sino Biological Description and Business Overview
Table 102. Sino Biological Anti-IFNAR1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sino Biological Anti-IFNAR1 Monoclonal Antibody Product
Table 104. Sino Biological Recent Developments/Updates
Table 105. Proteintech Group Company Information
Table 106. Proteintech Group Description and Business Overview
Table 107. Proteintech Group Anti-IFNAR1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Proteintech Group Anti-IFNAR1 Monoclonal Antibody Product
Table 109. Proteintech Group Recent Developments/Updates
Table 110. Cytek Biosciences Company Information
Table 111. Cytek Biosciences Description and Business Overview
Table 112. Cytek Biosciences Anti-IFNAR1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Cytek Biosciences Anti-IFNAR1 Monoclonal Antibody Product
Table 114. Cytek Biosciences Recent Developments/Updates
Table 115. ImmunoWay Biotechnology Company Information
Table 116. ImmunoWay Biotechnology Description and Business Overview
Table 117. ImmunoWay Biotechnology Anti-IFNAR1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. ImmunoWay Biotechnology Anti-IFNAR1 Monoclonal Antibody Product
Table 119. ImmunoWay Biotechnology Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Anti-IFNAR1 Monoclonal Antibody Distributors List
Table 123. Anti-IFNAR1 Monoclonal Antibody Customers List
Table 124. Anti-IFNAR1 Monoclonal Antibody Market Trends
Table 125. Anti-IFNAR1 Monoclonal Antibody Market Drivers
Table 126. Anti-IFNAR1 Monoclonal Antibody Market Challenges
Table 127. Anti-IFNAR1 Monoclonal Antibody Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-IFNAR1 Monoclonal Antibody
Figure 2. Global Anti-IFNAR1 Monoclonal Antibody Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Anti-IFNAR1 Monoclonal Antibody Market Share by Type: 2025 & 2032
Figure 4. Human Source Product Picture
Figure 5. Rat Source Product Picture
Figure 6. Other Product Picture
Figure 7. Global Anti-IFNAR1 Monoclonal Antibody Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Anti-IFNAR1 Monoclonal Antibody Market Share by Application: 2025 & 2032
Figure 9. Research Institute
Figure 10. Laboratory
Figure 11. Other
Figure 12. Global Anti-IFNAR1 Monoclonal Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Anti-IFNAR1 Monoclonal Antibody Market Size (US$ Million), 2021–2032
Figure 14. Global Anti-IFNAR1 Monoclonal Antibody Sales (K Units), 2021–2032
Figure 15. Global Anti-IFNAR1 Monoclonal Antibody Average Price (US$/Unit), 2021–2032
Figure 16. Anti-IFNAR1 Monoclonal Antibody Report Years Considered
Figure 17. Anti-IFNAR1 Monoclonal Antibody Sales Share by Manufacturers in 2025
Figure 18. Global Anti-IFNAR1 Monoclonal Antibody Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Anti-IFNAR1 Monoclonal Antibody Players: Market Share by Revenue in Anti-IFNAR1 Monoclonal Antibody in 2025
Figure 20. Anti-IFNAR1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Anti-IFNAR1 Monoclonal Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Country (2021–2032)
Figure 23. North America Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 24. United States Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Country (2021–2032)
Figure 27. Europe Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 28. Germany Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Region (2021–2032)
Figure 35. China Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Country (2021–2032)
Figure 43. Latin America Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Anti-IFNAR1 Monoclonal Antibody Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Anti-IFNAR1 Monoclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Anti-IFNAR1 Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Anti-IFNAR1 Monoclonal Antibody by Type (2021–2032)
Figure 54. Global Revenue Market Share of Anti-IFNAR1 Monoclonal Antibody by Type (2021–2032)
Figure 55. Global Anti-IFNAR1 Monoclonal Antibody Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Anti-IFNAR1 Monoclonal Antibody by Application (2021–2032)
Figure 57. Global Revenue Market Share of Anti-IFNAR1 Monoclonal Antibody by Application (2021–2032)
Figure 58. Global Anti-IFNAR1 Monoclonal Antibody Price (US$/Unit) by Application (2021–2032)
Figure 59. Anti-IFNAR1 Monoclonal Antibody Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
